PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director WEINSTEIN ROBERT
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director WALKER WAYNE REMELL
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director SCHECHTER JONATHAN
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director Abecassis Michael M
PharmaCyte Biotech | SC 13D: Statement of acquisition of beneficial ownership by individuals-PharmaCyte Biotech, Inc.(83.4%)
PharmaCyte Biotech | 3: Initial statement of beneficial ownership of securities-10% Owner PharmaCyte Biotech, Inc.
PharmaCyte Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%), etc.
PharmaCyte Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%), etc.
PharmaCyte Biotech | 3: Initial statement of beneficial ownership of securities-10% Owner PharmaCyte Biotech, Inc.
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director WEINSTEIN ROBERT
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director WALKER WAYNE REMELL
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Trujillo Carlos
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Silverman Joshua
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director SCHECHTER JONATHAN
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director Abecassis Michael M
PharmaCyte Biotech | SC 13D: Statement of acquisition of beneficial ownership by individuals-PharmaCyte Biotech, Inc.(37.0%)
PharmaCyte Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Iroquois Master Fund Ltd.(4.99%),Iroquois Capital Management, LLC(4.99%), etc.
PharmaCyte Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%), etc.
PharmaCyte Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Abbe(7.0%),Iroquois Master Fund Ltd.(6.6%), etc.
PharmaCyte Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Shay Capital LLC(0.00%),Shay Capital Holdings LLC(0.00%)
No Data